Show simple item record

dc.contributor.authorShaikh, Mushfiq H
dc.contributor.authorClarke, Daniel TW
dc.contributor.authorJohnson, Newell W
dc.contributor.authorMcMillan, Nigel AJ
dc.date.accessioned2017-06-02T12:00:29Z
dc.date.available2017-06-02T12:00:29Z
dc.date.issued2017
dc.identifier.issn1368-8375
dc.identifier.doi10.1016/j.oraloncology.2017.02.016
dc.identifier.urihttp://hdl.handle.net/10072/338492
dc.description.abstractConventional treatment strategies have done little to improve the prognosis or disease-free survival in head and neck cancer (HNC) patients. Recent progress in our understanding of molecular aspects of head and neck squamous cell carcinoma (HNSCC) has provided insights into the potential use of molecular targeted therapies in combination with current treatment strategies. Here we review the current understanding of treatment modalities for both HPV-positive and HPV-negative HNSCCs with the potential to use gene editing and silencing technologies therapeutically. The development of sequence-specific RNA interference (RNAi) with its strong gene-specific silencing ability, high target specificity, greater potency and reduced side effects, has shown it to be a promising therapeutic candidate for treating cancers. CRISPR/Cas gene editing is the newest technology with the ability to delete, mutate or replace genes of interest and has great potential for treating HNSCCs. We also discuss the major challenge in using these approaches in HNSCC; that being the choice of target and the ability to deliver the payload. Finally, we highlight the potential combination of RNAi or CRIPSR/Cas with current treatment strategies and outline the possible path to the clinic.
dc.description.peerreviewedYes
dc.languageEnglish
dc.publisherElsevier
dc.relation.ispartofpagefrom9
dc.relation.ispartofpageto19
dc.relation.ispartofjournalOral Oncology
dc.relation.ispartofvolume68
dc.subject.fieldofresearchCancer Therapy (excl. Chemotherapy and Radiation Therapy)
dc.subject.fieldofresearchDentistry
dc.subject.fieldofresearchOncology and Carcinogenesis
dc.subject.fieldofresearchPublic Health and Health Services
dc.subject.fieldofresearchcode111204
dc.subject.fieldofresearchcode1105
dc.subject.fieldofresearchcode1112
dc.subject.fieldofresearchcode1117
dc.titleCan gene editing and silencing technologies play a role in the treatment of head and neck cancer?
dc.typeJournal article
dc.type.descriptionC1 - Articles
dc.type.codeC - Journal Articles
gro.facultyGriffith Health, School of Dentistry and Oral Health
gro.hasfulltextNo Full Text
gro.griffith.authorMcMillan, Nigel
gro.griffith.authorJohnson, Newell W.
gro.griffith.authorClarke, Daniel
gro.griffith.authorShaikh, Mushfiq


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record